ArticleJournal of endovascular therapy : an official journal of the International Society of Endovascular Specialists2023
Intravascular Lithotripsy and Drug-Coated Balloon Angioplasty for Severely Calcified Femoropopliteal Arterial Disease.
Article in Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05916950 (The THOR IDE Study), which is not on this map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The THOR IDE Study
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.
- Pooled it
- Device design and applications of the novel JAVELIN peripheral intravascular lithotripsy catheter.Journal of vascular surgery cases and innovative techniques · 2026Article
- Intravascular Lithotripsy for Patients with Chronic Limb-Threatening Ischemia: Study Protocol for CALCIO, a Prospective Multicenter Observational Investigation.Cardiovascular and interventional radiology · 2026Observational
- Advanced Needle-Based Strategies for Complex Calcified Peripheral Artery Disease: A Systematic Review.Journal of the Society for Cardiovascular Angiography & Interventions · 2026Review
- Intravascular lithotripsy of the femoropopliteal arteries: analysis of a prospective two-center pilot study.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2026Article
- Intravascular Lithotripsy for Peripheral Arterial Disease: Outcomes From a Single-Center Experience.Cureus · 2026Article
- Analysis of the impact of nodular calcification on clinical outcome after drug-coated balloon angioplasty for femoropopliteal lesions.CVIR endovascular · 2025Article
- Two year comparative outcomes of drug coated balloons in long versus short femoropopliteal lesions.Scientific reports · 2025Article
- Femoropopliteal Interventions for Peripheral Artery Disease: A Review of Current Evidence and Future Directions.Interventional cardiology clinics · 2025Review
- Quantitative evaluation of IVL: based on the tunica media gypsum calcification model and a prospective animal study.Frontiers in cardiovascular medicine · 2025Article
- Early outcomes of drug-coated balloon angioplasty and stent placement for the treatment of iliac artery lesions.Frontiers in surgery · 2025Article
- Intravascular Lithotripsy and Drug-Coated Balloon Angioplasty for Severely Calcified Common Femoral Artery Atherosclerotic Disease.Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists · 2024Article
- I only believe what I see: Cracking the code of calcification.Journal of vascular surgery cases and innovative techniques · 2024Article
- Intravascular Lithotripsy for Peripheral Artery Calcification: Mid-term Outcomes From the Randomized Disrupt PAD III Trial.Journal of the Society for Cardiovascular Angiography & InterventionsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe combination of intravascular lithotripsy (IVL) and drug-coated balloon (DCB) angioplasty for calcified peripheral lesions is associated with promising short-term results. However, data regarding the 12 months performance of this treatment option is missing. This study reports on the outcomes of IVL and DCB angioplasty for calcified femoropopliteal disease.
methodsPatients treated with IVL and DCB for calcified femoropopliteal lesions between February 2017 and September 2020 were included into this study. The primary outcome measure of this analysis was primary patency. Secondary patency, freedom from target lesion revascularization (TLR) and overall mortality were additionally analyzed.
resultsFifty-five (
conclusionsIn this challenging cohort of patients, the use of IVL and DCB for calcified femoropopliteal lesions was associated with promising 12 months outcomes and an excellent safety profile.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.